UOC
IQMD

UBS O'Connor’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

UBS O'Connor’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-381,797
Closed -$3.85M – 663
2022
Q3 		$3.85M Sell
381,797
-38,221
-9% -$384K 0.04% 368
2022
Q2 		$4.21M Buy
+420,018
New +$4.2M 0.04% 370

Other funds holding IQMD

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

UBS O'Connor's IQMD Position: Q4 2022 in Review

UBS O'Connor sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q4 2022, closing a stake of 381,797 shares — an estimated $3.85M sold.

UBS O'Connor first reported a position in IQMD in Q2 2022 and held it in 2 quarters. The position peaked at $4.21M in Q2 2022. 60 funds tracked by Wall St. Rank hold IQMD as of Q4 2022.

  • UBS O'Connor reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 381,797 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.85M.
  • UBS O'Connor first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • UBS O'Connor's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $4.21M in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.